Abiopharma

SACHEM CAPITAL CORP. (SCCD)

Symbol	SCCD
Name	SACHEM CAPITAL CORP.
Sector	REAL ESTATE
Region	North America
Industry	Real Estate Investment Trusts
Address	568 EAST MAIN STREET, BRANFORD, Connecticut, 06405, United States
Telephone	+1 203 - 433-4736
Fax	—
Email	—
Website	https://www.sachemcapitalcorp.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ;NYSE MKT
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001682220
Description	Sachem Capital Corp is a United States-based real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. Additional info from NASDAQ: Sachem Capital Corp is a United States-based real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. Additional info from NYSE MKT: Sachem Capital Corp is a United States-based real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends.

2026-06-04 20:18

(99% Neutral) SACHEM CAPITAL CORP. (SCCG) Announces Business Combination

2026-06-04 20:15

Sachem Capital Corp. Announces Common and Preferred Dividends

2026-05-28 20:34

Sachem Capital Mourns the Passing of Board Member Arthur Goldberg

2026-05-20 11:06

(30% Negative) SACHEM CAPITAL CORP. (SCCG) Reports Q2 2026 Financial Results

2026-05-20 11:00

Sachem Capital Reports First Quarter 2026 Results

2026-05-20 08:07

New Form DEFA14A - Sachem Capital Corp. Filed: 2026-05-20 AccNo: 0001682220-26-000043 Size: 224 KB

2026-05-19 16:40

Sachem Capital Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Sachem Capital Corp. - SACH

2026-05-18 17:04

New Form DEFA14A - Sachem Capital Corp. Filed: 2026-05-18 AccNo: 0001682220-26-000032 Size: 276 KB

2026-05-18 17:04

New Form NT 10-Q - Sachem Capital Corp. Filed: 2026-05-18 AccNo: 0001682220-26-000031 Size: 93 KB

2026-05-18 13:32

Shareholder Alert: Ademi LLP investigates whether Sachem Capital Corp. is obtaining a Fair Price for Public Shareholders